150378-17-9,MFCD00866938
Catalog No.:AA001MH2

150378-17-9 | D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%(HPLC)powder
in stock  
$43.00   $30.00
- +
25mg
98%(HPLC)powder
in stock  
$107.00   $75.00
- +
100mg
98%(HPLC)powder
in stock  
$234.00   $164.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001MH2
Chemical Name:
D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-
CAS Number:
150378-17-9
Molecular Formula:
C36H47N5O4
Molecular Weight:
613.7895
MDL Number:
MFCD00866938
SMILES:
O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc1cccnc1)C[C@H](C(=O)N[C@@H]1[C@H](O)Cc2c1cccc2)Cc1ccccc1
Properties
Properties
 
BP:
877.9°C at 760 mmHg  
Form:
Solid  
MP:
150-153 °C  
Storage:
Keep in dry area;2-8℃;  


Downstream Synthesis Route

[1]CurrentPatentAssignee:RIZHAOPUDAPHARMACEUTICALTECH-CN108324716,2018,ALocationinpatent:Paragraph0017

[2]Askin,David;Eng,KanK.;Rossen,Kai;Purick,RobertM.;Wells,KennethM.;etal.[TetrahedronLetters,1994,vol.35,#5,p.673-676]

[1]Myers;Barbay;Zhong[JournaloftheAmericanChemicalSociety,2001,vol.123,#30,p.7207-7219]

[1]Dorsey;Levin;McDaniel;Vacca;Guare;Darke;Zugay;Emini;Schleif;Quintero;Lin;Chen-;Holloway;Fitzgerald;Axel;Ostovic;Anderson;Huff[JournalofMedicinalChemistry,1994,vol.37,#21,p.3443-3451]

[2]Askin,David;Eng,KanK.;Rossen,Kai;Purick,RobertM.;Wells,KennethM.;etal.[TetrahedronLetters,1994,vol.35,#5,p.673-676]

[3]Askin,David;Eng,KanK.;Rossen,Kai;Purick,RobertM.;Wells,KennethM.;etal.[TetrahedronLetters,1994,vol.35,#5,p.673-676]

[1]JournalofMedicinalChemistry,1994,vol.37,p.3443-3451

[1]JournalofMedicinalChemistry,1994,vol.37,p.3443-3451

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:150378-17-9 Molecular Formula|150378-17-9 MDL|150378-17-9 SMILES|150378-17-9 D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-
Catalog No.: AA001MH2
150378-17-9,MFCD00866938
150378-17-9 | D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-
Pack Size: 5mg
Purity: 98%(HPLC)powder
in stock
$43.00 $30.00
Pack Size: 25mg
Purity: 98%(HPLC)powder
in stock
$107.00 $75.00
Pack Size: 100mg
Purity: 98%(HPLC)powder
in stock
$234.00 $164.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001MH2
Chemical Name: D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-
CAS Number: 150378-17-9
Molecular Formula: C36H47N5O4
Molecular Weight: 613.7895
MDL Number: MFCD00866938
SMILES: O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc1cccnc1)C[C@H](C(=O)N[C@@H]1[C@H](O)Cc2c1cccc2)Cc1ccccc1
Properties
BP: 877.9°C at 760 mmHg  
Form: Solid  
MP: 150-153 °C  
Storage: Keep in dry area;2-8℃;  
Downstream Synthesis Route
3099-31-8    150323-38-9    150378-17-9 

[1]CurrentPatentAssignee:RIZHAOPUDAPHARMACEUTICALTECH-CN108324716,2018,ALocationinpatent:Paragraph0017

[2]Askin,David;Eng,KanK.;Rossen,Kai;Purick,RobertM.;Wells,KennethM.;etal.[TetrahedronLetters,1994,vol.35,#5,p.673-676]

116-11-0    150378-17-9    185213-44-9 

[1]Myers;Barbay;Zhong[JournaloftheAmericanChemicalSociety,2001,vol.123,#30,p.7207-7219]

150323-35-6    150378-17-9 

[1]Dorsey;Levin;McDaniel;Vacca;Guare;Darke;Zugay;Emini;Schleif;Quintero;Lin;Chen-;Holloway;Fitzgerald;Axel;Ostovic;Anderson;Huff[JournalofMedicinalChemistry,1994,vol.37,#21,p.3443-3451]

[2]Askin,David;Eng,KanK.;Rossen,Kai;Purick,RobertM.;Wells,KennethM.;etal.[TetrahedronLetters,1994,vol.35,#5,p.673-676]

[3]Askin,David;Eng,KanK.;Rossen,Kai;Purick,RobertM.;Wells,KennethM.;etal.[TetrahedronLetters,1994,vol.35,#5,p.673-676]

848482-93-9    150378-17-9 

[1]JournalofMedicinalChemistry,1994,vol.37,p.3443-3451

150407-69-5    150378-17-9 

[1]JournalofMedicinalChemistry,1994,vol.37,p.3443-3451

Building Blocks More >
182250-70-0
182250-70-0
3,5-Bis(tert-butyldiphenylsilyloxy)benzyl alcohol
AA0023FK | MFCD02093440
261761-26-6
261761-26-6
5-[4-(tert-Butyl)phenyl]-4-(4-isopropylphenyl)-4h-1,2,4-triazole-3-thiol
AA002RXL | MFCD00207958
3425-89-6
3425-89-6
4-Methyl-4-cyclohexene-1,2-dicarboxylic anhydride
AA003AWT | MFCD00023106
74832-72-7
74832-72-7
4-(2,4-Dichlorophenylsulfonyl)morpholine
AA003JUL | MFCD01116430
1317-33-5
1317-33-5
Molybdenum(IV) Sulfide
AA003S2E | MFCD00003470
761440-87-3
761440-87-3
1-(4-Amino-3-methoxyphenyl)piperidin-4-ol
AA0057MH | MFCD18861046
42308-20-3
42308-20-3
Propanamide, 2-bromo-N-phenyl-
AA0072NG | MFCD00012228
1182-34-9
1182-34-9
Cynarin
AA00815H | MFCD13196510
1092533-91-9
1092533-91-9
3-Bromo-4-fluorophenylboronic acid
AA008YZ6 | MFCD13195642
1214322-99-2
1214322-99-2
2-Bromo-6-fluorophenylacetic acid
AA009GE1 | MFCD13185377
Submit
© 2017 AA BLOCKS, INC. All rights reserved.